BioPharma Credit PLC
BPCP.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £1,059,827 | £1,183,492 | £1,279,227 | £1,353,472 |
| - Cash | £5,620 | £86,202 | £120,527 | £94,709 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £1,054,207 | £1,097,290 | £1,158,700 | £1,258,763 |
| Revenue | £124,457 | £135,737 | £184,245 | £87,969 |
| % Growth | -8.3% | -26.3% | 109.4% | – |
| Gross Profit | £124,457 | £135,737 | £184,245 | £87,969 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | £122,178 | £0 | £0 | £0 |
| % Margin | 98.2% | 0% | 0% | 0% |
| Net Income | £122,178 | £108,450 | £182,311 | £84,959 |
| % Margin | 98.2% | 79.9% | 99% | 96.6% |
| EPS Diluted | 0.1 | 0.083 | 0.13 | 0.062 |
| % Growth | 20.8% | -36.3% | 110.4% | – |
| Operating Cash Flow | £111,912 | £123,182 | £184,277 | £96,436 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | £111,912 | £123,182 | £184,277 | £96,436 |